Navigation Links
Off-Label Avastin Use for Wet Macular Degeneration
Date:2/25/2008

Treatment Could Save Millions Their Sight

PORTLAND, Ore., Feb. 25 /PRNewswire/ -- The Food and Drug Administration (FDA) has only approved Avastin for cancer of the colon and lungs. In off-label use, however, Avastin is proving itself as a "miracle drug" that's currently used by some doctors to treat other cancers, including breast, prostate, renal cell, head and neck, pancreatic, ovarian and hepatocellular.

Some ophthalmologists are also turning to Avastin for wet age-related macular degeneration (AMD), the leading cause of blindness in people over 50 years old. Wet AMD is a growing concern for aging adults. There are 200,000 new cases of the disease every year and experts project the number will increase rapidly as baby boomers age and their life expectancy increases. Experts estimate 6.3 million people will lose their vision to wet AMD by 2030. They also predict the disease will cost half a million people their sight each year.

In wet AMD, abnormal blood vessels grow at the back of the eye and leak blood and fluids into the macula, the central part of the retina. Like a high-definition digital camera, the eye's macula picks up fine-grained pictures so you can see their detail. Untreated wet AMD rapidly causes rapid vision loss and without the macula you cannot read fine print, recognize faces or drive.

"Because wet AMD is a devastating disease that progresses swiftly, ophthalmologists want to treat it immediately," explains Dr. Skip Freedman, executive medical director at AllMed Healthcare Management, a leading independent review organization (IRO). "And there is strong medical evidence that Avastin and Luncentis are the most effective treatment for wet AMD today."

According to Freedman, both drugs bind and inactivate the growth of blood vessels in the macula. In 2006, the FDA approved Genentech's Luncentis for wet AMD. However, because Genentech researchers derived both Luncentis and Avastin from the same mo
'/>"/>

SOURCE AllMed Healthcare Management
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study looks at off-label use of biliary stents
2. FDA Panel Says No to Avastin for Advanced Breast Cancer
3. Taxol with avastin produces noteworthy results
4. Many More Patients Can Now Benefit from Avastins Proven Survival Benefits
5. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
6. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
7. FDA OKs Avastin for Advanced Breast Cancer
8. $37 million financing for company based on macular degeneration research
9. Model to study age-related macular degeneration could pave way for better treatment
10. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
11. Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... When the weather turned ... debuted their new type of sod called Leisure Time(TM) zoysia . It's nicknamed ... , To commemorate introduction of this new type of sod, Super-Sod is giving away ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Precision Aesthetics is ... years. It was also the first provider of Exilis non-surgical fat reduction in ... after procedures it has attracted a large International clientele. Many patients travel to ...
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... Sculpted ... , the CoolSmooth PRO this week. Zeltiq Aesthetics released this new applicator in ... in January 2014 for treating the outer thighs. The original applicator required a ...
(Date:7/31/2015)... ... July 31, 2015 , ... Coco Libre announced today that their ... VIPs at the 2015 Vans US Open of Surfing, July 25 through August 2 ... “no added sugar” on the market, is a natural choice given the Open’s commitment ...
(Date:7/31/2015)... , ... July 31, 2015 , ... According to an ... experts gathered to see if they could reach a consensus on the steps that ... and facelifts. Overall, the group reached 90 percent consensus on a series of steps ...
Breaking Medicine News(10 mins):Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... Texas, Feb. 6 Oncology Metrics,a business that ... the treatment of cancer, today announced the launch ... to assist community,oncology practices understand critical operating measures., ... all community-based oncology,practices nationally. Practices of all size ...
... Feb. 6 Cejka Search, a nationally ... announced that,several of its leaders will deliver ... Audio Conference and the American,College of Healthcare ... Audio Conference: Retention Strategies to Keep Top ...
... either alpha-hydroxy acid or beta-hydroxy acid are both highly effective ... the Saint Louis University School of Medicine have found ... acid peels as therapies for the skin disorder. , Peels ... and results that lasted a bit longer than did peels ...
... as cancer cells spread throughout living zebrafish,s body , , ... now get a clearer view into human biology and ... zebrafish, a common model for medical research. , According ... new breed, zebrafish are genetically similar to humans. ...
... asks board member to seek restatement of Beth ... Massbank director Allan,Bufferd should apply the same ... companies to his role on the board of ... group 1199 SEIU United,Healthcare Workers East. Bufferd is ...
... Galaxy Nutritional,Foods (OTC Bulletin Board: GXYF), a leading ... organic and natural food,products, today announced that it will ... the third quarter for the 2008 fiscal year at,11:00 ... plans to report its,operating results before the market opens ...
Cached Medicine News:Health News:Oncology Metrics Launches the National Practice Benchmark: One in a Series of Initiatives to Help Community Oncology Practices Better Measure Operational and Financial Performance 2Health News:Cejka Search Experts Present Latest Developments in Physician Retention and CEO Leadership Skills 2Health News:Treating acne: 2 different acid peels are both effective, study finds 2Health News:Transparent Fish Gives New Window on Disease 2Health News:Massbank Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008 2
(Date:7/30/2015)... 30, 2015  EP Global Communications, Inc. (Public OTC: ... contacted the Company about discussing EPGL,s electronic contact ... Monday, August 3, 2015.  Novartis CEO Joe ... the coming electronic contact lens market could be ... next several years.  Novartis partnered with Google in ...
(Date:7/30/2015)... and VANCOUVER , July 30, ... announced today that it will report its second quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
(Date:7/30/2015)... THOUSAND OAKS, Calif. , July 30, 2015  Amgen ... Fred Hassan , partner and managing director of Warburg Pincus ... "We are pleased to welcome Fred Hassan and ... to the Amgen Board," said Robert A. Bradway , ... expertise and commitment to innovation will serve Amgen well." ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3
... June 08, 2007 /PRNewswire-FirstCall/ --,Lexicon Pharmaceuticals, Inc. today ... research project with scientists at Fox,Chase Cancer Center ... Lexicon researchers have discovered a novel and,surprising role ... T lymphocytes. These findings have been published in,the ...
... - NuPathe Inc., a,privately held specialty pharmaceutical ... Phase I study of NP101,SmartRelief, a novel ... NP101 combines NuPathe's SmartRelief(TM) proprietary,iontophoretic transdermal technology ... acute migraine in the United,States. Sumatriptan is ...
Cached Medicine Technology:Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 2Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 3NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly l...
Bipolar forceps...
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
... superb radiation protection-0.62mm (+/- .05)Pb lead glass ... to their level of protection, they are ... smoothly on your bridge while hugging your ... wear corrective lenses, you can order Leaded ...
Medicine Products: